This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • HIV/AIDS  • Tuberculosis/ Other Mycobacterium  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Bonnie S. Slovis, MD, MSHS; Jonathan D. Plitman, MD; David W. Haas, MD

JAMA. 2000;283:2003-2007.

Although anergy testing is commonly used to help interpret negative tuberculin skin test results, the validity of this approach has not been demonstrated. Specific issues include lack of a standardized protocol for antigen selection, number needed to reliably evaluate inability to respond, and uniform criteria for defining cutaneous reactivity, as well as regional variation in skin test reactivity. Tuberculin skin testing is used to screen for latent infection and to evaluate the need for isoniazid prophylaxis. The presence or absence of reactivity to control antigens does not affect this decision. The results of anergy testing also do not predict the risk for progression to active disease in either HIV-negative or HIV-positive patients. In HIV-negative patients with active tuberculosis, 10% to 20% have negative tuberculin test results, and 5% to 10% have a negative tuberculin result but have a positive reaction to another antigen. A negative tuberculin skin test result does not exclude either latent infection or active disease, even in the presence of a reaction to other antigens. Neither anergy testing nor tuberculin testing obviates the need for microbiologic evaluation when there is suspicion for active tuberculosis infection. Therefore, anergy testing is not useful in screening for asymptomatic tuberculous infection or for diagnosing active tuberculosis.

Author Affiliations: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn (Drs Slovis and Haas); and High Point Gastroenterology Associates, High Point, NC (Dr Plitman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

April 19, 2000
JAMA. 2000;283(15):2041-2042.
EXTRACT | FULL TEXT  

Testing for Tuberculosis
JAMA. 2000;283(15):2060.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Assessment of risk for pulmonary tuberculosis after non-reactive tuberculin skin testing among patients with HIV infection in a resource-limited setting
Khawcharoenporn et al.
Int J STD AIDS 2008;19:843-847.
ABSTRACT | FULL TEXT  

Detecting Latent Tuberculosis Infection in Hemodialysis Patients: A Head-to-Head Comparison of the T-SPOT.TB Test, Tuberculin Skin Test, and an Expert Physician Panel
Passalent et al.
CJASN 2007;2:68-73.
ABSTRACT | FULL TEXT  

Interferon-{gamma} Assays for Tuberculosis: Is Anergy the Achilles' Heel?
Pai and Lewinsohn
Am. J. Respir. Crit. Care Med. 2005;172:519-521.
FULL TEXT  

Latent tuberculosis: revised treatment guidelines
Weir and Fisman
CMAJ 2003;169:937-938.
FULL TEXT  

Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts
Long et al.
CMAJ 2003;169:789-791.
FULL TEXT  

Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia
Delgado et al.
Proc. Natl. Acad. Sci. USA 2002;99:7576-7581.
ABSTRACT | FULL TEXT